Your browser doesn't support javascript.
loading
PBK/TOPK enhances aggressive phenotype in prostate cancer via ß-catenin-TCF/LEF-mediated matrix metalloproteinases production and invasion.
Brown-Clay, Joshua D; Shenoy, Deepika N; Timofeeva, Olga; Kallakury, Bhaskar V; Nandi, Asit K; Banerjee, Partha P.
Affiliation
  • Brown-Clay JD; Department of Biochemistry and Molecular and Cellular Biology, Georgetown University Medical Center, Washington, DC, USA.
  • Shenoy DN; Department of Biochemistry and Molecular and Cellular Biology, Georgetown University Medical Center, Washington, DC, USA.
  • Timofeeva O; Departments of Oncology and Radiation Medicine, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA.
  • Kallakury BV; Department of Pathology, Georgetown University Medical Center, Washington, DC, USA.
  • Nandi AK; Current address: Cockeysville, Maryland.
  • Banerjee PP; Department of Biochemistry and Molecular and Cellular Biology, Georgetown University Medical Center, Washington, DC, USA.
Oncotarget ; 6(17): 15594-609, 2015 Jun 20.
Article in En | MEDLINE | ID: mdl-25909225

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Biomarkers, Tumor / Mitogen-Activated Protein Kinase Kinases / Beta Catenin / TCF Transcription Factors Type of study: Prognostic_studies Limits: Humans / Male Language: En Journal: Oncotarget Year: 2015 Document type: Article Affiliation country: United States Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Biomarkers, Tumor / Mitogen-Activated Protein Kinase Kinases / Beta Catenin / TCF Transcription Factors Type of study: Prognostic_studies Limits: Humans / Male Language: En Journal: Oncotarget Year: 2015 Document type: Article Affiliation country: United States Country of publication: United States